AstraZeneca Doubles Down on US Investment
AstraZeneca announces a $2 billion investment in the US, expanding its research, development, and manufacturing. The CEO clarifies that the decision is primarily based on confidence in the US economy, not solely on political factors.
AstraZeneca Doubles Down on US Investment
AstraZeneca announces a $2 billion investment in the US, expanding its research, development, and manufacturing. The CEO clarifies that the decision is primarily based on confidence in the US economy, not solely on political factors.
Progress
0% Bias Score
AstraZeneca Q3 Results: Strong Earnings Despite China Concerns
AstraZeneca's Q3 earnings exceeded expectations, boosting 2024 projections, despite legal issues in China.
AstraZeneca Q3 Results: Strong Earnings Despite China Concerns
AstraZeneca's Q3 earnings exceeded expectations, boosting 2024 projections, despite legal issues in China.
Progress
0% Bias Score
Reig Jofre: From Pharmacy to Pharmaceutical Leader
Reig Jofre's journey from a small pharmacy to a leading pharmaceutical company, highlighting its growth, challenges, and future plans.
Reig Jofre: From Pharmacy to Pharmaceutical Leader
Reig Jofre's journey from a small pharmacy to a leading pharmaceutical company, highlighting its growth, challenges, and future plans.
Progress
0% Bias Score
Ineffective Cold Remedies
A pharmacy expert and a GP discuss the ineffectiveness of oral phenylephrine in cold and flu remedies, prompting the FDA to consider a ban.
Ineffective Cold Remedies
A pharmacy expert and a GP discuss the ineffectiveness of oral phenylephrine in cold and flu remedies, prompting the FDA to consider a ban.
Progress
0% Bias Score
Global Medical Companies Target Chinese Market at CIIE
Global medical companies are leveraging the China International Import Expo (CIIE) to access the vast Chinese market, showcasing their latest advancements in pharmaceuticals and medical devices.
Global Medical Companies Target Chinese Market at CIIE
Global medical companies are leveraging the China International Import Expo (CIIE) to access the vast Chinese market, showcasing their latest advancements in pharmaceuticals and medical devices.
Progress
0% Bias Score
CIIE Showcases Medical Innovations
Medical companies showcased advanced technologies and products at the China International Import Expo (CIIE) in Shanghai.
CIIE Showcases Medical Innovations
Medical companies showcased advanced technologies and products at the China International Import Expo (CIIE) in Shanghai.
Progress
0% Bias Score
Kennedy's Plan to Make America Healthy Again
Robert F. Kennedy Jr.'s plan to combat chronic diseases involves major changes to food policy, pharmaceutical regulation, vaccine transparency, and water fluoridation.
Kennedy's Plan to Make America Healthy Again
Robert F. Kennedy Jr.'s plan to combat chronic diseases involves major changes to food policy, pharmaceutical regulation, vaccine transparency, and water fluoridation.
Progress
0% Bias Score
AstraZeneca Cooperates with Chinese Drug Importation Probe
AstraZeneca faces investigations in China over the importation of cancer drugs, impacting its share price but not its overall strong financial outlook.
AstraZeneca Cooperates with Chinese Drug Importation Probe
AstraZeneca faces investigations in China over the importation of cancer drugs, impacting its share price but not its overall strong financial outlook.
Progress
0% Bias Score
Trump's Health Agenda: Global Implications
Analysis of the potential global impacts of President-elect Trump's health policies, including trade, research funding, regulatory changes, and infectious disease monitoring.
Trump's Health Agenda: Global Implications
Analysis of the potential global impacts of President-elect Trump's health policies, including trade, research funding, regulatory changes, and infectious disease monitoring.
Progress
0% Bias Score
New Treatments for Non-Communicable Diseases Launched in Uganda
C&D Pharma launches three innovative treatments for non-communicable diseases in Uganda with support from the Ministry of Health and other partners.
New Treatments for Non-Communicable Diseases Launched in Uganda
C&D Pharma launches three innovative treatments for non-communicable diseases in Uganda with support from the Ministry of Health and other partners.
Progress
0% Bias Score
CIIE Showcases Global Medical Innovations
Medical companies showcased cutting-edge technologies and products at the CIIE in Shanghai, including Illumina's new sequencer, Gilead's new drug, and Johnson & Johnson's latest medical solutions.
CIIE Showcases Global Medical Innovations
Medical companies showcased cutting-edge technologies and products at the CIIE in Shanghai, including Illumina's new sequencer, Gilead's new drug, and Johnson & Johnson's latest medical solutions.
Progress
0% Bias Score
Novo Nordisk Q3 Earnings Beat Expectations
Novo Nordisk's Q3 earnings beat expectations, driven by strong Wegovy sales, despite supply challenges. The company narrowed its 2024 growth guidance and is investing in increased production capacity.
Novo Nordisk Q3 Earnings Beat Expectations
Novo Nordisk's Q3 earnings beat expectations, driven by strong Wegovy sales, despite supply challenges. The company narrowed its 2024 growth guidance and is investing in increased production capacity.
Progress
0% Bias Score